Cargando…

Dosimetric Coverage of the Prostate, Normal Tissue Sparing, and Acute Toxicity with High-Dose-Rate Brachytherapy for Large Prostate Volumes

PURPOSE: To evaluate dosimetric coverage of the prostate, normal tissue sparing, and acute toxicity with HDR brachytherapy for large prostate volumes. MATERIALS AND METHODS: One hundred and two prostate cancer patients with prostate volumes >50 mL (range: 5-29 mL) were treated with high-dose-rate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, George, Strom, Tobin J., Wilder, Richard B., Shrinath, Kushagra, Mellon, Eric A., Fernandez, Daniel C., Biagioli, Matthew C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752135/ https://www.ncbi.nlm.nih.gov/pubmed/26200536 http://dx.doi.org/10.1590/S1677-5538.IBJU.2014.0289

Ejemplares similares

Quality of life after high-dose-rate brachytherapy monotherapy for prostate cancer
por: Contreras, Jessika A., et al.
Publicado: (2015)

Determining Combined Modality Dosimetric Constraints by Integration of IMRT and LDR Prostate Brachytherapy Dosimetry and Correlation with Toxicity
por: Riegel, Adam C., et al.
Publicado: (2022)

Evaluation of the dosimetric impact of loss and displacement of seeds in prostate low-dose-rate brachytherapy
por: Wang, Yinkun, et al.
Publicado: (2015)

The impact of body mass index on dosimetric quality in low-dose-rate prostate brachytherapy
por: Echevarria, Michelle I., et al.
Publicado: (2016)

Incorporating Routine Magnetic Resonance Imaging-based Planning for the Delivery of High-dose-rate Brachytherapy for Prostate Cancer: An Evaluation of Clinical Feasibility and Dosimetric Outcomes
por: Saigal, Kunal, et al.
Publicado: (2019)

Dosimetric analysis and comparison of IMRT and HDR brachytherapy in treatment of localized prostate cancer
por: Murali, V., et al.
Publicado: (2010)

Dosimetric effects of prone and supine positions on post-implant assessments for prostate brachytherapy
por: Ohashi, Toshio, et al.
Publicado: (2013)

Determination of dosimetric parameters for shielded (153)Gd source in prostate cancer brachytherapy
por: Ghorbani, Mahdi, et al.
Publicado: (2017)

Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience
por: Ito, Masaya, et al.
Publicado: (2023)

Template guided transperineal saturation biopsy of the prostate: lessons for focal and urethra-sparing high-dose-rate brachytherapy for localized prostate cancer
por: Novikov, Sergey Nikolaevich, et al.
Publicado: (2016)

Dosimetric outcomes of preoperative treatment planning with intraoperative optimization using stranded seeds in prostate brachytherapy
por: Lee, Jason Joon Bock, et al.
Publicado: (2022)

Coverage with dosimetric concordance index (CDCI): a tool for evaluating dosimetric impact of inter-observer target variability in brachytherapy
por: Upreti, Ritu Raj, et al.
Publicado: (2020)

Low dose rate prostate brachytherapy
por: Stish, Bradley J., et al.
Publicado: (2018)

Indications for additional volume studies for gland volume estimation in prostate cancer brachytherapy
por: Khanolkar, Rutvij A, et al.
Publicado: (2022)

High dose-rate brachytherapy in the treatment of prostate cancer
por: Mendez, Lucas C., et al.
Publicado: (2018)

Predicting toxicity caused by high-dose-rate brachytherapy single boost for prostate cancer
por: Olsén, Johan Staby, et al.
Publicado: (2022)

Dosimetric comparison of inverse optimisation methods versus forward optimisation in HDR brachytherapy of breast, cervical and prostate cancer
por: Fröhlich, Georgina, et al.
Publicado: (2019)

Dose Distribution of High Dose-Rate and Low Dose-Rate Prostate Brachytherapy at Different Intervals—Impact of a Hydrogel Spacer and Prostate Volume
por: Haddad, Hathal, et al.
Publicado: (2023)

Sensitivity of dose‐volume indices to computation settings in high‐dose‐rate prostate brachytherapy treatment plan evaluation
por: van der Meer, Marjolein C., et al.
Publicado: (2019)

Feasibility and early toxicity of focal or partial brachytherapy in prostate cancer patients
por: Kim, Tae Heon, et al.
Publicado: (2020)

Prostate volume and implant configuration during 48 hours of temporary prostate brachytherapy: limited effect of oedema
por: Dinkla, Anna M, et al.
Publicado: (2014)

Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: toxicity, prostate-specific antigen kinetics, and cancer control
por: Mayrata, Esther, et al.
Publicado: (2021)

Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy
por: Hirose, Katsumi, et al.
Publicado: (2017)

The phylogeny of permanent prostate brachytherapy
por: Aronowitz, Jesse N., et al.
Publicado: (2013)

Evaluation of the effect of prostate volume change on tumor control probability in LDR brachytherapy
por: Knaup, Courtney, et al.
Publicado: (2011)

Plan Quality Index – An Integrated Dosimetric Approach for Plan Evaluation with Consideration of Quality of Dose Coverage to Tumors and Quality of Organs’ Sparing
por: Krishnan, Jayapalan, et al.
Publicado: (2022)

Periodical assessment of genitourinary and gastrointestinal toxicity in patients who underwent prostate low-dose-rate brachytherapy
por: Tanaka, Nobumichi, et al.
Publicado: (2013)

Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
por: Kunogi, Hiroaki, et al.
Publicado: (2020)

High-dose-rate brachytherapy boost for prostate cancer: rationale and technique
por: Morton, Gerard C.
Publicado: (2014)

Correlations of post-implant regional dosimetric parameters at 24 hours and one month, with clinical results of low-dose-rate brachytherapy for localized prostate cancer
por: Okazaki, Eiichiro, et al.
Publicado: (2017)

Pre-implant magnetic resonance and transrectal ultrasound imaging in high-dose-rate prostate brachytherapy: comparison of prostate volumes, craniocaudal extents, and contours
por: Grisotto, Simone, et al.
Publicado: (2018)

A comparison of preplan MRI and preplan CT-based prostate volume with intraoperative ultrasound-based prostate volume in real-time permanent brachytherapy
por: Park, Hyeli, et al.
Publicado: (2011)

Evaluation of rectal volume correlation with dosimetric parameters during optimized intracavitary high-dose-rate brachytherapy in cervical cancer
por: Shahbazian, Hodjatollah, et al.
Publicado: (2020)

Radiation-Induced Leiomyosarcoma of the Prostate after Brachytherapy for Prostatic Adenocarcinoma
por: Horiguchi, Hiroto, et al.
Publicado: (2014)

Vital role of volume and number of needles in HDR brachytherapy (HDR-BT) of prostate cancer
por: Chicheł, Adam, et al.
Publicado: (2009)

Rectal dose to prostate cancer patients treated with proton therapy with or without rectal spacer
por: Chung, Heeteak, et al.
Publicado: (2016)

The current role of imaging for prostate brachytherapy
por: Carey, Brendan, et al.
Publicado: (2007)

Photoacoustic imaging of prostate brachytherapy seeds
por: Su, Jimmy L., et al.
Publicado: (2011)

Prostate brachytherapy: HDR or seed implant
por: Das, K. R.
Publicado: (2006)

Prostate cancer brachytherapy: guidelines overview
por: Wojcieszek, Piotr, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_iemvd1fvhpofd8he08b5i2eccj